FDA Takes Contaminated Heparin From Ohio Drug Co.

Law360, New York (November 6, 2008, 12:00 AM EST) -- The U.S. Food and Drug Administration on Thursday seized 11 contaminated lots of heparin made with materials imported from China by Cincinnati-based Celsus Laboratories Inc. in the agency's latest action involving the controversial drug thinner.

The agency said the drug contained over-sulfated chondroitin sulfate, the same contaminant found in many heparin stocks during the summer amid panic over more than 100 reports of deaths linked to the drug since January. OSCS imitates heparin's anticoagulant characteristics, and the FDA said in April that it believed the contaminant...
To view the full article, register now.

UK Financial Services

UK Financial Services

Read Our Latest UK Financial Services Coverage

Financial Services Law360 UK provides breaking news and analysis on the financial sector. Coverage includes UK and European Union policy, enforcement, and litigation involving banks, asset management firms, and other financial services organizations.